メタ情報
| meta description平均長 | 114.86 |
|---|
| OGPありページ数 | 78 |
|---|
| Twitterカードありページ数 | 78 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 534 |
|---|
| ページあたり内部リンク平均 | 164.77 |
|---|
内部リンク 深さヒストグラム
| キー | 値 |
|---|
| 0 | 44 |
| 1 | 684 |
| 2 | 10530 |
| 3 | 1561 |
| 5 | 25 |
| 6 | 5 |
| 7 | 2 |
| 8 | 1 |
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| など | 1 |
| every | 0.872908 |
| insight | 0.825598 |
| best | 0.800563 |
| our | 0.800563 |
| across | 0.800563 |
| helped | 0.800563 |
| companies | 0.800563 |
| GLGは | 0.79588 |
| how | 0.785618 |
| 英語 | 0.715356 |
| 動画を見る | 0.715356 |
| 詳細を見る | 0.662182 |
| クライアントソリューション | 0.536517 |
| また | 0.484641 |
| power | 0.467839 |
| COO | 0.420345 |
| EVP | 0.420345 |
| Prior | 0.420216 |
| these | 0.420216 |
| atValo | 0.419203 |
| Health | 0.419203 |
| sheserved | 0.418884 |
| Series | 0.418884 |
| neuroscience | 0.418884 |
| Sanofi | 0.416716 |
| atPfizer | 0.416716 |
| Wyeth | 0.416716 |
| Previous | 0.416716 |
| includes | 0.416716 |
| genetic | 0.416409 |
| medicine | 0.416409 |
| Previously | 0.416409 |
| currently | 0.412844 |
| Stylus | 0.412844 |
| Medicine | 0.412844 |
| Survey | 0.412799 |
| atReata | 0.412799 |
| Pharmaceuticals | 0.412799 |
| AstraZeneca | 0.412799 |
| IPO | 0.408241 |
| Best | 0.407357 |
| Practices | 0.407357 |
| Learn | 0.407357 |
| surveys | 0.407357 |
| can | 0.407357 |
| take | 0.407357 |
| you | 0.407357 |
| suppositions | 0.407357 |
| certainty | 0.407357 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Anne | Marie | 5.898028 | 800 |
| Gerson | Lehrman | 5.690268 | 408 |
| development | drug | 5.396925 | 400 |
| Officer | SVP | 5.396925 | 400 |
| HEC | Paris | 5.396925 | 400 |
| more | than | 5.396925 | 400 |
| Britain | Great | 5.383614 | 400 |
| BtoB調査 | アンケート調査 | 5.327822 | 392 |
| GlaxoSmithKline | plc | 5.149904 | 250 |
| duty | royal | 5.07457 | 200 |
| インタビュー | エキスパート | 5.030598 | 196 |
| drug | regulatory | 4.954685 | 350 |
| development | regulatory | 4.954685 | 350 |
| Chief | Officer | 4.954685 | 350 |
| Agency | Medical | 4.954685 | 350 |
| イベント | ライブラリー | 4.883912 | 209 |
| BtoB調査 | 受託調査 | 4.86571 | 343 |
| New | York | 4.862076 | 204 |
| logos | trademarks | 4.845835 | 200 |
| affairs | manufacturing | 4.845835 | 200 |
| commercialization | manufacturing | 4.845835 | 200 |
| commercialization | within | 4.845835 | 200 |
| biopharma | within | 4.845835 | 200 |
| biopharma | industry | 4.845835 | 200 |
| large | scale | 4.845835 | 200 |
| organizationalrestructuring | scale | 4.845835 | 200 |
| organizationalrestructuring | transformation | 4.845835 | 200 |
| integration | transformation | 4.845835 | 200 |
| capital | raising | 4.845835 | 200 |
| investorrelations | raising | 4.845835 | 200 |
| investorrelations | pre | 4.845835 | 200 |
| IPO | pre | 4.845835 | 200 |
| Medicine | Stylus | 4.845835 | 200 |
| genetic | medicine | 4.845835 | 200 |
| Previously | sheserved | 4.845835 | 200 |
| Series | neuroscience | 4.845835 | 200 |
| Prior | these | 4.845835 | 200 |
| COO | EVP | 4.845835 | 200 |
| EVP | atValo | 4.845835 | 200 |
| Health | atValo | 4.845835 | 200 |
| Wyeth | atPfizer | 4.845835 | 200 |
| Previous | Wyeth | 4.845835 | 200 |
| Pharmaceuticals | atReata | 4.845835 | 200 |
| Directors | Hansa | 4.845835 | 200 |
| Biopharma | Hansa | 4.845835 | 200 |
| Adthera | Biopharma | 4.845835 | 200 |
| Adthera | Bio | 4.845835 | 200 |
| Neuropharmacology | inMolecular | 4.845835 | 200 |
| BSc | Neuropharmacology | 4.845835 | 200 |
| BSc | Physiology | 4.845835 | 200 |
被リンク情報
このデータの閲覧には会員登録が必要になります。会員登録